Jason Gardner, See Remarks at Magenta Therapeutics, Inc. (MGTA), sold 2,800 shares at $15.10 ($42K) on 2020-01-02, disclosed to the SEC on 2020-01-03.
Scheduled sale ($42k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MGTA | SELL | 2019-12-23 | $44K | — | Filing → |
| MGTA | SELL | 2019-12-20 | $2.3M | — | Filing → |
| MGTA | SELL | 2019-12-13 | $133K | — | Filing → |